Ten Capital Wealth Advisors’s Edwards Lifesciences EW Stock Holding History

Ten Capital Wealth Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-62	Closed	-$5K	–	614
2022 Q3	$5K	Buy	62 +23	+59%	+$2.21K	﹤0.01%	402
2022 Q2	$4K	Hold	39	–	–	﹤0.01%	347
2022 Q1	$5K	Hold	39	–	–	﹤0.01%	370
2021 Q4	$5K	Hold	39	–	–	﹤0.01%	367
2021 Q3	$4K	Hold	39	–	–	﹤0.01%	334
2021 Q2	$4K	Buy	+39	New	+$3.68K	﹤0.01%	384

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ten Capital Wealth Advisors's EW Position: Q4 2022 in Review

Ten Capital Wealth Advisors sold out of Edwards Lifesciences (EW) in Q4 2022, closing a stake of 62 shares — an estimated $5K sold.

Ten Capital Wealth Advisors first reported a position in EW in Q2 2021 and held it in 6 quarters. The position peaked at $5K in Q3 2022. 1,228 funds tracked by Wall St. Rank hold EW as of Q4 2022.

Ten Capital Wealth Advisors reported no remaining Edwards Lifesciences position as of Q4 2022 after selling out during the quarter.
Ten Capital Wealth Advisors sold 62 Edwards Lifesciences shares in Q4 2022, an estimated $5K.
Ten Capital Wealth Advisors first reported a position in Edwards Lifesciences in Q2 2021 and held it in 6 quarters.
Ten Capital Wealth Advisors's Edwards Lifesciences position peaked at $5K in Q3 2022.
1,228 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2022.

Based on Ten Capital Wealth Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.